TGFB1 and renal fibrosis: Multiple in vivo studies of different renal-related diseases revealed that after silencing Smad 3, the fibrosis process was alleviated, suggesting that Smad 3 can be a critical pathogenic mediator of TGF-β/Smad signaling in renal fibrosis [65,66,67,68].